Griseofulvin adverse reactions: Difference between revisions
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Griseofulvin}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Adverse Reactions== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b876327f-d496-46a7-ae39-011baaad6aa7 | publisher = | date = | accessdate = }}</ref> | When adverse reactions occur, they are most commonly of the hypersensitivity type such as skin rashes, urticaria and rarely, [[angioneurotic edema]] or [[erythema multiforme]]-like drug reaction, and may necessitate withdrawal of therapy and appropriate countermeasures. Paresthesias of the hands and feet have been reported rarely after extended therapy. Other side effects reported occasionally are oral thrush, nausea, vomiting, epigastric distress, diarrhea, headache, fatigue, dizziness, insomnia, mental confusion and impairment of performance of routine activities. | ||
[[Proteinuria]] and [[leukopenia]] have been reported rarely. Administration of the drug should be discontinued if [[granulocytopenia]] occurs. | |||
When rare, serious reactions occur with griseofulvin, they are usually associated with high dosages, long periods of therapy, or both.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b876327f-d496-46a7-ae39-011baaad6aa7 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 23:23, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Adverse Reactions
When adverse reactions occur, they are most commonly of the hypersensitivity type such as skin rashes, urticaria and rarely, angioneurotic edema or erythema multiforme-like drug reaction, and may necessitate withdrawal of therapy and appropriate countermeasures. Paresthesias of the hands and feet have been reported rarely after extended therapy. Other side effects reported occasionally are oral thrush, nausea, vomiting, epigastric distress, diarrhea, headache, fatigue, dizziness, insomnia, mental confusion and impairment of performance of routine activities.
Proteinuria and leukopenia have been reported rarely. Administration of the drug should be discontinued if granulocytopenia occurs.
When rare, serious reactions occur with griseofulvin, they are usually associated with high dosages, long periods of therapy, or both.[1]
References
Adapted from the FDA Package Insert.